MedPath

XGEN PHARMACEUTICALS DJB, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

FDA:22

Drug Approvals

edaravone

Approval Date
Mar 28, 2025
FDA

Voriconazole

Approval Date
Mar 26, 2024
FDA

Desmopressin Acetate

Approval Date
Mar 22, 2024
FDA

Pentamidine Isethionate

Approval Date
Mar 18, 2024
FDA

PENTAMIDINE ISETHIONATE

Approval Date
Jan 25, 2024
FDA

PROMETHAZINE HYDROCHLORIDE

Approval Date
Jan 9, 2024
FDA

Acetazolamide

Approval Date
Jan 5, 2024
FDA

PROMETHAZINE HYDROCHLORIDE

Approval Date
Jan 5, 2024
FDA

Ibuprofen Lysine

Approval Date
Jan 1, 2024
FDA

CYCLOPHOSPHAMIDE

Approval Date
Dec 19, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.